Medical/Pharmaceuticals

Ally Bridge Group Leads US$70 million Investments in Two Israeli Life Science Companies over the Last 2 Months

TEL AVIV, Israel, HONG KONG and NEW YORK, Feb. 18, 2020 /PRNewswire/ — Ally Bridge Group ("ABG"), a leading global life science investment group, has announced that it recently ledUS$70 million investments in two Israeli life science companies over the last 2 months. Each of the two companies is ...

2020-02-18 21:30 1804

WAT Medical's study finds that HeadaTerm TENS Therapy Provides a Fast Treatment for Acute Migraines in a Randomized Controlled Trial

VANCOUVER, Feb. 14, 2020 /PRNewswire/ -- WAT Medical is thrilled to announce the newest clinical study conducted for an anti-migraine device by the  HeadaTerm,for the treatment of migraines. The HeadaTerm TENS device was shown to decrease pain at an 11.8% better rate than many acute migraine medic...

2020-02-14 22:00 1474

Immuron reports diarrhea no.1 health issue for Americans on vacation

NEW YORK, Feb. 12, 2020 /PRNewswire/ -- Diarrhea remains the top health issue facing Americans traveling to high risk countries, affecting 30 to 70 per cent of travelers depending upon their destination, according to biopharmaceutical company Immuron Limited[1], [2].

2020-02-13 04:35 1187

Lianluo Smart Limited Announces Pricing of Approximately $2.2 Million Offering

BEIJING, Feb. 12, 2020 /PRNewswire/ -- Lianluo Smart Limited ("Lianluo Smart" or the "Company") (NASDAQ: LLIT), aChina based professional smart service and products provider announced today it has entered into a securities purchase agreement with certain accredited investors to purchase approxima...

2020-02-13 01:57 9926

GC Pharma Reports Full Year 2019 Results

All consolidated entities revenues grew plus compared to prior year YONGIN, South Korea, Feb. 12, 2020 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the year ended31 December 201...

2020-02-12 22:00 9962

WuXi AppTec China Sites Resume Operations after Extended Lunar New Year Holiday

SHANGHAI, Feb. 12, 2020 /PRNewswire/ -- With the end of the extended Lunar New Year holiday, WuXi AppTec sites inChina have resumed operations today, with the exception of our site inWuhan, which will reopen when local regulations permit. These steps are being taken in compliance with disease con...

2020-02-12 20:00 1414

WuXi Biologics Provides Back-to-work Operation Update Related to the Coronavirus Outbreak

SHANGHAI, Feb. 11, 2020 /PRNewswire/ -- WuXi Biologics is closely monitoring the coronavirus outbreak. Our management team is working vigilantly to execute our Business Continuity Plan to mitigate any potential risk. All three operating sites inChina, namely Wuxi, Shanghai and Suzhou, will resume...

2020-02-12 08:00 6822

111 Partners with Winhealth to Offer "Free Refill + End-to-End Delivery" Services to Patients with Chronic Diseases

SHANGHAI, Feb. 11, 2020 /PRNewswire/ -- As the novel coronavirus epidemic continues to evolve inChina, the country has introduced controls to prevent the spread of the epidemic and reduce the risk of contagion. Among the measures adopted is home quarantine, which has created challenges for patien...

2020-02-12 06:00 7379

With favorable policies, the medical device industry may usher in explosive growth; Medtec China offers a platform to seize the business opportunities

SHANGHAI, Feb. 11, 2020 /PRNewswire/ -- Reccently, the demand for medical devices such as protective clothing and masks soared, as did demand for devices including POCT testing reagents for theIVD industry, nucleic acid extraction devices, gene sequencing technology,medical imaging devices such a...

2020-02-11 22:00 1250

Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel® and Seroquel XR® in South Africa and Certain Neighbouring Countries

HONG KONG, Feb. 10, 2020 /PRNewswire/ -- Luye Pharma Group has announced that it has entered into an exclusive distribution and marketing service agreement with Cipla Medpro South Africa (Pty) Limited (Cipla Medpro), for Seroquel® and Seroquel XR® in South Africa, Namibia and Botswana. Cipla Medp...

2020-02-11 08:51 1324

Yuyu's First Generic Newmacor's 5-year Cumulative Sales Surpasses 40 Million Capsules

* Lined up all the sold Newmacor capsules end-to-end would reach 1,043km * Future target growth is to reach blockbuster levels and exceed 10 billion KRW SEOUL, South Korea, Feb. 10, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) is celebrating the 5th anniversary of the ...

2020-02-10 22:00 1557

GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours

NANJING, China, Feb. 6, 2020 /PRNewswire/ -- On February 4, 4:46 a.m., escorted by public security officers, 8 transgenic mice for fully human antibodies immunized with antigen from 2019 nCoV from Rongchang District,Chongqing were brought by Chongqing Academy of Animal Sciences and Chongqing CAMA...

2020-02-06 22:46 1715

Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director

HONG KONG, Feb. 6, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr.Siu Chuen Chen...

2020-02-06 19:30 7063

Bridge Biotherapeutics Acquires a New Drug Development Candidate for Back-Eye Diseases

* Signed a collaboration and license agreement for developing back-eye disease treatments with Konkuk University in the Republic of Korea * A total of 10B KRW deal includes 300M KRW of upfront payment SEONGNAM, South Korea, Feb. 5, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical ...

2020-02-05 13:21 1154

United Imaging Sends Out More than 100 CT Scanners and X-Ray Machines to Aid Diagnosis of the Coronavirus

HOUSTON, Feb. 4, 2020 /PRNewswire/ -- United Imaging employees across the globe extend our thoughts and condolences to those affected by the coronavirus. To help front-line physicians, nurses, and other healthcare professionals diagnose and treat the coronavirus, United Imaging has donated medica...

2020-02-04 21:00 1486

Samsung Biologics Reports 64% Jump in FY19 Earnings, Sees Global Expansion in 2020

INCHEON, South Korea, Feb. 4, 2020 /PRNewswire/ -- Samsung Biologics, a pharmaceutical Contract Manufacturing Organization (CMO), recorded high for the fiscal year 2019, reporting 30.9% growth in sales at701.6 billion won, and 64.6% growth in operating profit at91.7 billion won compared to the ...

2020-02-04 13:50 1055

China Jo-Jo Drugstores Steps in to Help Combat the 2019 Novel Coronavirus

HANGZHOU, China, Feb. 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services inChina, today an...

2020-02-04 06:00 7930

CStone successfully hosted the first U.S. R&D Day in New York

* Among CStone's 15 cancer drug candidates, five candidates are in pivotal late-stage clinical development, with a total of 13 on-going registrational trials. * The Company has implemented its pipeline strategy for early-stage candidates and combination therapy. With an established clinical d...

2020-01-24 08:03 2574

Saluda Medical Highlights Multiple Presentations Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting

Includes 8 Oral Presentations and Award of Best Clinical Abstract ARTARMON, Australia, Jan. 21, 2020 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that data from multiple studies evaluating the company's Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (...

2020-01-21 20:00 991

Transcenta Announces Acceptance by NMPA of IND Application of a Novel Humanized Claudin 18.2 Monoclonal Antibody

SUZHOU and HANGZHOU, China, Jan. 20, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D and manufacturing of antibody-based therapeutics, announces today that an investigational new drug (IND) appl...

2020-01-21 00:00 913